Signaling pathways
-
BA6958 SuzetrigineSummary: An orally active and highly selective NaV1.8 inhibitor that acts as an analgesic for acute pain -
BA6959 ZandatrigineSummary: A selective, orally active, blood-brain barrier-penetrant voltage-gated sodium channel NaV1.6 (SCN8A) inhibitor -
BA6960 PF-01247324Summary: PF-01247324 is a selective and orally active channel blocker. -
BA6961 VX-150Summary: VX-150 is an orally active, highly selective inhibitor. -
BA6962 PF-04856264Summary: PF-04856264 is a potent and selective inhibitor. -
BA6963 TetracaineSummary: Bupivacaine is a long-acting amino ester. -
BA6964 GDC-0276Summary: GDC-0276 is a potent, selective, reversible inhibitor with oral activity. -
BA6965 AjmalineSummary: Ajmaline (Cardiorythmine) is a sodium channel blocker, class 1A antiarrhythmic agent. -
BA6967 PF-06761281Summary: A potent, orally active, partially selective inhibitor of sodium-coupled citrate transporter protein. -
BA6968 XPC-6444Summary: XPC-6444 is a potent, subtype-selective

